Home / Inspections / 1141818

FDA Inspection 1141818 — Andrew P. Brockmyre, MD

Andrew P. Brockmyre, MD — FEI 3017865465

The FDA completed an inspection of Andrew P. Brockmyre, MD on April 28, 2021 in Bristol, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bristol, TN (United States)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources